Phenotyping sarcoidosis: a single institution retrospective analysis
- PMID: 40400623
- PMCID: PMC12092213
- DOI: 10.3389/fmed.2025.1590102
Phenotyping sarcoidosis: a single institution retrospective analysis
Abstract
Introduction: Sarcoidosis is a systemic disorder marked by the presence of non-caseating epithelioid cell granulomas. The diagnosis relies on a consistent clinical presentation, histological evidence of non-necrotizing granulomatous inflammation in one or more tissue specimens, and the exclusion of other potential etiologies of granulomatous disease. It is a heterogeneous disease with many focal points to be clarified. For instance, finding a relationship between symptom burden, race, gender, HRQoL, and pulmonary function could have therapeutic ramifications, influence clinical practice, and aid in selecting patients for specific clinical studies.
Methods: A comprehensive statistical evaluation was conducted using the JMP partitioning algorithm which explores all potential divisions to identify the most predictive variables.
Results: With our analysis, we tried to categorize patients from a single Institution respiratory unit to delineate clinical phenotypes in sarcoidosis.
Conclusions: Larger studies using appropriate methodology should surely be carried out to address this issue and help clarify the varying contributions of genetics, socioeconomic status, environmental exposures, and other sociodemographic factors to illness severity and phenotypic presentation. Additionally, the application of transcriptomics, interdisciplinary methods, patients' disease perspectives, and the publishing of novel discoveries may contribute to enhanced clinical support and a deeper comprehension of the etiology of illness.
Keywords: granulomatous diseases; inflammatory granulomatous diseases; interstitial lung disease; phenotyping; sarcoidosis.
Copyright © 2025 Bertuccio, Piloni, Russo, Tousa, Crescenzi, Putignano, Baio, Maragò, Corsico and Stella.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Phenotypes and Serum Biomarkers in Sarcoidosis.Diagnostics (Basel). 2024 Mar 27;14(7):709. doi: 10.3390/diagnostics14070709. Diagnostics (Basel). 2024. PMID: 38611622 Free PMC article. Review.
-
[Granulomatous diseases and pathogenic microorganism].Kekkaku. 2008 Feb;83(2):115-30. Kekkaku. 2008. PMID: 18326339 Japanese.
-
Potential use of biomarkers for the clinical evaluation of sarcoidosis.J Investig Med. 2021 Jan 15:jim-2020-001659. doi: 10.1136/jim-2020-001659. Online ahead of print. J Investig Med. 2021. PMID: 33452128 Review.
-
The pathology of pulmonary sarcoidosis: update.Semin Diagn Pathol. 2007 Aug;24(3):150-61. doi: 10.1053/j.semdp.2007.06.002. Semin Diagn Pathol. 2007. PMID: 17882899 Review.
-
Reprint of: The pathology of pulmonary sarcoidosis: update.Semin Diagn Pathol. 2018 Sep;35(5):324-333. doi: 10.1053/j.semdp.2018.09.001. Epub 2018 Sep 24. Semin Diagn Pathol. 2018. PMID: 30262157
References
LinkOut - more resources
Full Text Sources
